Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
Blockchain supply chain business smart contract solution network protocol - illustration rendering | Image Credit - © immimagery - © immimagery - stock.adobe.com
With the bio/pharmaceutical industry facing patent expirations in the near-term for key drugs, bio/pharma companies are facing the pressure of staying competitive in a bio/pharmaceutical landscape where the therapies are growing increasingly complex amid a major shift toward personalized medicines. Pharmaceutical Technology® spoke with Informa Markets about the critical role outsourcing plays in today’s competitive environment as well as into the future.
Read this article in Pharmaceutical Technology’s Bio/Pharma Outsourcing Innovation eBook.
Chris Spivey is the editorial director of Pharmaceutical Technology® and Pharmaceutical Technology Europe®.
Pharmaceutical Technology/Pharmaceutical Technology Europe Outsourcing Innovation eBook
Issue 2
February 2024
Pages: 31-32
When referring to this article, please cite it as Spivey, C. Pharmaceutical Outsourcing Present and Future. Pharmaceutical Technology, Bio/Pharma Outsourcing Innovation eBook. February 2024.
Market Demands and Emerging Technologies Shape Outsourcing Models
June 5th 2025Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.